Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation

Bibliographic Details
Main Authors: Yao Sun, Xiaohui Zhang, Liangding Hu, Muhammad Bilal Abid
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1248270/full
_version_ 1797782889686892544
author Yao Sun
Xiaohui Zhang
Liangding Hu
Muhammad Bilal Abid
author_facet Yao Sun
Xiaohui Zhang
Liangding Hu
Muhammad Bilal Abid
author_sort Yao Sun
collection DOAJ
first_indexed 2024-03-13T00:18:20Z
format Article
id doaj.art-68bce68cd9a64d8a89349fed98eaa886
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T00:18:20Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-68bce68cd9a64d8a89349fed98eaa8862023-07-11T18:41:35ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-07-011410.3389/fimmu.2023.12482701248270Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantationYao Sun0Xiaohui Zhang1Liangding Hu2Muhammad Bilal Abid3Senior Department of Hematology, The Fifth Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, ChinaBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, ChinaSenior Department of Hematology, The Fifth Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, ChinaDivisions of Hematology/Oncology & Infectious Diseases, BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1248270/fullallogeneic stem cell transplantacute leukemiachimeric antigen receptorIFN-alenalidomidegraft-versus-host-disease
spellingShingle Yao Sun
Xiaohui Zhang
Liangding Hu
Muhammad Bilal Abid
Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation
Frontiers in Immunology
allogeneic stem cell transplant
acute leukemia
chimeric antigen receptor
IFN-a
lenalidomide
graft-versus-host-disease
title Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation
title_full Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation
title_fullStr Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation
title_full_unstemmed Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation
title_short Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation
title_sort editorial novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation
topic allogeneic stem cell transplant
acute leukemia
chimeric antigen receptor
IFN-a
lenalidomide
graft-versus-host-disease
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1248270/full
work_keys_str_mv AT yaosun editorialnovelmechanismandstrategiestoovercomerelapseafterallogeneicstemcelltransplantation
AT xiaohuizhang editorialnovelmechanismandstrategiestoovercomerelapseafterallogeneicstemcelltransplantation
AT liangdinghu editorialnovelmechanismandstrategiestoovercomerelapseafterallogeneicstemcelltransplantation
AT muhammadbilalabid editorialnovelmechanismandstrategiestoovercomerelapseafterallogeneicstemcelltransplantation